Wednesday, May 03, 2023 Congratulations to the PR22 Team Centre hospitalier universitaire de Sherbrooke who were recognized with the Phase III Team Award for Intergroup-Led Trials at the CCTG Spring Meeting. This award is presented to trial teams from member centres for performance in trial accrual, local activation timelines, compliance metrics and team performance. “It is with great pleasure and honour that we receive this prestigious award today on behalf of all current and former members of our research team at the Centre Hospitalier Universitaire de Sherbrooke. Our success is based on the commitment and professionalism of all our research staff and doctors, and our patients' willingness to be partners in our research efforts. Over the years, our Center has contributed to more than 30 CCTG studies, and has ranked among the top recruiters for MA.20 (170pts), PR.13 (120pts), PR.7, SC.20, and currently PR.22 with more than 47pts under the leadership of Dr. Ebacher our local PI for this study. We must also acknowledge the major contributions of Dr. Abdenour Nabid and Ms. Sophie Couture, research nurse, over the last two decades. We sincerely thank the CCTG for this recognition, and our best wishes of success for the current and future CCTG protocols, promising that Sherbrooke will continue to join forces with all our Canadian colleagues to build a better future for our patients.” The team includes: Dr. Audrey Tétreault-Laflamme, Dr. Annie Ebacher, Dr. Abdenour Nabid, Dr. Laurence Masson-Côté, Dr. Myriam Bouchard, Hélène Dion, Cynthia Ladouceur, Sophie Couture
